Preliminary research published in Nature suggests that COVID-19 vaccines, particularly Pfizer and Moderna, may offer unexpected benefits for cancer patients.
Breakdown
- Researchers observed that mRNA COVID-19 vaccines may activate the immune system in cancer patients. 10s
- A study of 1,000 patients showed lung cancer patients who received the vaccine survived nearly twice as long as those who did not. 34s
- The vaccine appears to enhance the effectiveness of immunotherapy by reprogramming the immune system. 44s
- Patients who did not initially respond to immunotherapy had a five-fold improvement in survival after vaccination. 54s
- Researchers plan to conduct a phase three clinical trial to further study these findings. 1m 29s